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Abstract
Background: Classic wound drainage is still common in
hip replacement but its benefit is doubtful. the role of
systemic  administration  of  proteinase  inhibitors  like
aprotinin to avoid perioperative blood loss is still un-
clear.
Patients and Methods: In a prospective randomized tri-
al, the perioperative blood loss in alloplastic hip re-
placement under the influence of proteinase inhibitor
(aprotinin, trasylolﾮ) using wound drainage as well as
compression treatment alone were compared. 80 pa-
tients were prospectively randomized in 4 arms. Pa-
tients  received  either  aprotinin  or  placebo  during
surgery as well as drainage or targeted external wound
compression.
Results: observing the “drug therapy” aprotinin had
no  effect  on  the  intra-  or  postoperative  blood  loss
(p>0.05), a trend to lower postoperative hemoglobin
decline was found, but without significance. throm-
bosis  occurred  in  neither  the  aprotinin  nor  in  the
placebo group. two patients had a severe allergic drug
reaction  and  were  excluded  from  the  study.  under
”non  drug  therapy”  with  compression  therapy  and
wound drainage a significant difference in blood loss
was found (p<0.001). the blood loss was higher under
the wound drainage. there was no influence on the in-
fection rate. yet we could observe increased bruising
under the sole external compression treatment.
Conclusion: the  administration  of  aprotinin  did  not
achieve the desired reduction of perioperative blood
loss. Hence, costs and two severe allergic drug reac-
tions in our study represent arguments against its use
in  regular  treatment.  Furthermore,  it  seems  that
wound drainage is neglectable in hip replacement and
can be substituted by a sole compression treatment.
Key words: total hip replacement, wound drainage, drug
reaction, aprotinin, trasylolﾮ, compression treatment
IntRoduCtIon
surgical dissection of soft tissue and bone in arthro-
plasty of the hip joint can cause substantial bleeding
and is responsible for intra- and postoperative blood
loss. the intraoperative blood loss can be reduced by
using mainly blunt tissue dissection as far as possible,
reduction  of  tissue  trauma,  local  hypothermia  and
pharmacological influence on the body's blood coagu-
lation mechanism [22, 42, 56]. Furthermore, the post-
operative blood loss is influenced by the effectiveness
and durability of the body's own hemostasis, external
tissue compression, and particularly by the method of
wound drainage. In 1954, the French surgeons Redon,
Jost  and  torque  evacuated  glass  bottles  to  promote
drainage of wound secretion after surgery. this was
the  beginning  of  the  era  of  postoperative  suction
drains [7, 9, 10, 12].
the idea behind wound drainage is an optimized
balance of secretion and accumulation of blood and
the  internal  adaptation  and  stabilization  of  wounds.
over the years, the drainage technique developed with
various modifications [18-21, 23, 25]. Aiming to avoid
postoperative complications and to provide additional
positive effects on wound healing, the postoperative
secretion drainage using Redon drains is now a stan-
dard method for European orthopaedic-trauma sur-
geons  [15].  However,  there  are  serious  numbers  of
complications possibly caused by wound drainage [24,
26, 29, 31].
one major disadvantage is the risk for retrograde
wound  contamination  with  bacteria.  other  reasons
are the cytoadhesive properties of polymeric drainage
systems, increased postoperative blood loss caused by
the contact of the drains with tissue surfaces.  there
are also arguments of injured vessels and impairment
of wound healing through foreign body reaction as
well  as  the  release  of  toxic  plasticizers,  especially
when using drainage made of polyvinyl chloride [24,
26, 31, 32]. Concomitantly, numerous studies have ad-
dressed the positive effects of a drainage free surgical
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wound  drainage  can  be  waived  for  certain  surgical
procedures without the risk of impaired wound heal-
ing. the question is whether the prophylactic use of
suction drains for the patient really is an important
procedure to prevent complications or whether it in-
creases  the  risk  for  postoperative  blood  loss  and
wound infections [32]. 
Another cause of increased blood loss in arthro-
plasty can be an imbalance in the hemostasis system
[29, 61]. tissue injury induces the release of proteolyt-
ic substances which increase fibrinolysis, leading to a
relative lack of endogenous proteinase inhibitors like
α-antiplasmin  and  α-macroglobulin.  the  proteinase
inhibitor aprotinin (trasylolﾮ Bayer, germany) inter-
rupts this mechanism, as it interferes in regulating the
mechanisms of bleeding and thereby may reduce peri-
operative blood loss. Aprotinin, a kallikrein inactivator,
was discovered in 1930. It was isolated in 1936 as a
trypsin inhibitor by Kunitz and northrop from bovine
tissue [4, 5, 35, 40]. these results have been confirmed
by many studies showing that aprotinin is able to in-
hibit a variety of proteinases. Royston and co-workers
showed  that  high  doses  of  aprotinin  during  cardiac
surgery significantly reduced blood loss [50]. Although
this effect was achieved through an inhibition of fibri-
nolysis,  there  was  no  increased  rate  of  thrombosis.
these results triggered a growing interest in aprotinin
and led to a number of studies in cardiac-, vascular-,
liver- and in orthopedic surgery [3-5, 11].
the investigation of our study was whether there is
a need for suction wound drainage in cement less hip
replacement im comparison of wound compression.
on the other hand, we sought to analyze whether an
intraoperative administration of proteinase inhibitors
like aprotinin may lead to a reduction of the perioper-
ative blood loss. 
PAtIEnts, MAtERIAls And MEtHods
In a prospective randomized study, patients older than
18 years undergoing elective implantation of cement
less arthroplasty of the hip due to manifest coxarthro-
sis were included (Fig. 1). the study was approved by
the local Ethics Committee. Patients with a known in-
tolerance to aprotinin, pre-existing coagulation disor-
ders or undergoing drug therapy for regulating coagu-
lation were excluded from the study.
the study was a prospective, randomized double-
blind parallel trial with 4 arms comparing 80 patients
(intention to treat) (51-80 years, 43♀, 38♂). We com-
pared trasylolﾮ against placebo in one trial and suc-
tion drains versus external compression on the other.
All patients were exclusively treated by 2 experienced
surgeons  participating  in  earlier  studies.  drugs  con-
sumed by the patients on admission and during the
course of the study were recorded as adjunctive thera-
py in the protocol. Adverse events between consent
and beginning of the studyand the causality between
event and study procedure were documented. under-
current diseases and manifestations were considered as
"adverse events" and were reported. In totally 80 pa-
tients could be included for the trials. From this over-
all population group, 2 x 40 patients were randomized
receiving  either for receiving intraoperative 250 ml of
a solution containing 500ku of trasylolﾮ or 250 ml
0.9% naCl as a placebo. In addition, each group was
subdivided into two arms, either with wound drainage
by suction drainages, (n = 20 ) or with a specific exter-
nal wound compression (n = 20) (Fig. 2).
the  implantation  of  cement  less  hip  arthroplasty
type zweym￼ller was carried out on the transgluteal
access according to the Bauer procedure.
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Fig. 1. study design.
Fig. 2. External wound compression in a patient.
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the  randomized  information  whether  the  wound
should  be  treated  with  two  (subcutaneous  and  sub-
fascial  located)  suction  “Redon”  drains  or  with 
external  compression  (Fig.  2).  drains  were  removed 
at the 2nd postoperative day. there was a daily inspec-
tion  and  clinical  documentation  of  the  wound 
healing.
dIAgnostIC tEsts
Loss of  blood
A  main  objective  of  this  study  was  to  analyze  the
amount of perioperative blood loss, resulting from the
intraoperative  blood  loss,  blood  loss  via  wound
drainage and the size of the hematoma constituted at
the wound area.
the intraoperative blood loss was calculated based
on the collected amount of fluid. the intraoperative
administered amount of volume of Ringer’s solution
was  subtracted  from  the  total  amount  of  fluid
trapped. therefore all swabs and tissues were weighed
pre- and postoperatively. the difference between the
pre-operative and postoperative weight was divided by
the specific gravity of blood (1.06 mg / ml). For all
patients with suction drains, the entire post-operative
blood loss of suction bottle was documented.
All patients received ultrasound (us) diagnostic by
the same examiner screening for hematoma at the 2nd
and 14th postoperative day. the volume of the detect-
ed hematomas by us performed was added to the pe-
rioperatively counted loss of blood.
Blood samples were drawn for every patient preop-
eratively  and  at  the  1st and  2nd postoperative day.
Blood transfusions were performed and documented
according to the approved study protocol  (Hb <8
mg/l). All patients received a duplex ultrasound to ex-
clude or objective venous thrombosis on the 2nd post-
operative day.
stAtIstICs
the influence of two factors- “drug-” (aprotinin/ pla  -
cebo) and “non drug therapy” (drainage/compression)
- were examined.
data collection was carried out with the spreadsheet
program Excel and data processing with the statistical
programs sAs and sPss version 16. All data were col-
lected in boxplots and the median was described. 
the significance level was set at p < 0.05. Compari-
son of the groups was descriptive for important para-
meters such as age and gender. A two-way analysis of
variance was performed for the total blood loss and
exploratory at first for hemoglobin and the 2nd post-
operative  day,  respectively.  the  analysis  of  variance
was tested for interactions. 
REsults
Each group of patients was equal concerning the de-
mographic data. two patients, one in the drainage -
and one in the compression group developed a severe
allergic reaction after trasylolﾮ medication and were
excluded from further analysis, resulting in a final pop-
ulation of 78 patients. 
IntRAoPERAtIvE Blood loss
the patients in the trasylolﾮ group (n = 37) reached a
median blood loss of 507 ml (123-1141 ml). the me-
dian blood loss in the placebo group (n = 40) was 517
ml (132-1226 ml). In comparison  of the medians pa-
tients with trasylolﾮ lost 10 ml more blood periopera-
tively than patients with a naCl the placebo, the latter
had a larger range. these results were however not sta-
tistically significant. 
Blood loss tHRougH tHE suCtIon dRAIns
18 patients with intraoperative drainage receiving tra-
sylolﾮ had a median blood loss of 620 ml (190-1525
ml). 20 patients with intraoperative naCl placebo lost
a median of 615 ml (100-1260 ml) blood, resulting in a
median of 5 ml less blood loss in the trasylolﾮ-treated
group.
soFt tIssuE sonogRAPHy
In  one  patient  of  the  trasylolﾮ/drainage  group,  a
hematoma with the size of 12.3 ml on the 2nd postop-
erative  day  was  observed,  which  did  not  further  in-
crease (5.6%, 1/18 ). 
In one patient in the trasylolﾮ/compression group,
a hematoma with a size of 32.6 ml on the 2nd postop-
erative day developed, which was reduced on the 14th
postoperative day to 14.4 ml (5%, 1 / 20). 
In the placebo/drainage group 4 patients showed
hematomas  in  the  operated  wound  area,  3  hema-
tomas  of  10.5  ml,  11.8  ml  and  7.4  ml  were  found 
on  the  2nd postoperative  day.  one  hematoma  in-
creased  in  fourteen  days  to  a  size  of  32.6  ml. 
Furthermore,  one  hematoma  was  diagnosed  on  the 
8th postoperative day with bleeding after drainage re-
moval at the 2nd postoperative day. one patient, whose
examination was without result on the 2nd postopera-
tive  day,  developed  on  the  14th postoperative  day  a
hematoma of 11.8 ml. (20%, 4/20).
Five hematomas (average size 18.7 ml, range 10.0 –
35.2) in the placebo group/ compression group were
diagnosed on the second postoperative day , one of
these increased in fourteen days to a size of 14.3 ml.
on the 14th postoperative day, bruises of 25.0 ml and
12.5 ml were seen in two patients (35%, 7/20). 
summarized,  the  trasylolﾮ/Redon  group  showed
the lowest number of total hematoma.
PERIoPERAtIvE Blood loss
Patients  in  the  trasylolﾮ/drainage  arm  (n  =  18)
showed  a  median  blood  loss  of  1201  ml  (704-1648
ml). oppositely, the trasylolﾮ/compression group (n
= 20), presented with a median blood loss of 596 ml
(245-1141 ml). the blood loss in the placebo/drainage
group (n = 20) had a median of 1223 ml (592-1756
ml), while in the placebo/compression group (n = 20)
a  median  blood  loss  of  554  ml  (143-1063  ml)  was
measured. 
the blood loss under the influence of the “drug
therapy” with trasylolﾮ was not significantly different
from placebo (p = 0.7540). 
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a significantly higher blood loss in the wound treat-
ment  with  suction  drainage  instead  of  compression
(p<0.001).
Blood tRAnsFusIon
In the trasylolﾮ/Redon group (n=18), 10 patients re-
quired  blood  transfusions  within  48  hours  (56%),
while 7 out of 20 patients (35%) from the trasylolﾮ/
compression group required a blood transfusion (p =
0.02). similar, in seven out of 20 patients (35%) in the
placebo/Redon  group,  blood  transfusion  was  per-
formed, while nine of 20 patients (45%) in the place-
bo/compression  group  needed  a  blood  transfusion.
variance and interaction analysis of variance showed a
significant interaction regarding higher blood loss in
the  "non-drug  therapy"  with  suction  drainage  (p
<0.001)  in  contrast  to  compression.  through  the 
application  of  trasylolﾮ the  blood  loss  did  not 
change significantly (p = 0.75). Interactions were not
detectable (p = 0.74). A re-analysis of variance with
neglect  of  the  interaction  analysis  showed  a  signifi-
cantly higher blood loss through the use of suction
drains (p < 0.001), for the factor 'non-drug therapy’
but for the medical treatment no statistically signifi-
cant change after trasylolﾮ application was observed
(p = 0.75).
ERytHRoCytEs
the mean of erythrocyte concentration of the trasy-
lolﾮ/drainage group (n = 18) was preoperatively 4.1 x
106 /ﾵl (3.6 - 5.0 x 106/ﾵl), decreased on the 1st post-
operative day to 3.5 x 106/ﾵl (2.8 - 4.0 x 106/ﾵl) and
remained constant on the 2nd postoperative day with
3.5 x 106/ﾵl (2.8 to 4.1 x106/ﾵl). 
For the trasylolﾮ/compression group (n = 20), the
mean of preoperative red blood cell concentration was
4.2 x 106/ﾵl (3,4 - 5,0 x 106/ﾵl), decreased on the 1st
postoperative day to 3.6 x 106/ﾵl (1.8 - 4.2 x 106/ﾵl)
and on the 2nd postoperative day to 3.5 x 106/ﾵl (2.8
to 4.1 x 106/ﾵl). 
Preoperatively, the mean erythrocyte concentration
of  the  group  placebo/drainage  (n  =  20)  was  4.4  x
106/ﾵl (3.5 - 5.0 x 106/ﾵl), decreased to on the 1st
postoperative day to 3.3 x 106/ﾵl (2.9 to 4.1 x 106/ﾵl)
and remained unchanged on the 2nd postoperative day
with 3.3 x 106/ﾵl (2.7 to 3.9 x 106/ﾵl). 
the  mean  of  erythrocyte  concentration  in  the
placebo group/compression (n = 20) was preopera-
tively 4.3 x 106/ﾵl (3.3 to 5.2 x 106/ﾵl) and felt at the
first  postoperative  days  to  3.4  x  106/ﾵl  (2.7  -  4.0  x
106/ﾵl)  and  on  the  2nd  postoperative  day  to  3.1  x
106/ﾵl (2.6 to 3.9 x 106/ﾵl).
Patients treated with trasylolﾮ had a smaller post-
operative decrease in red cell concentration than the
placebo groups. the highest difference was found on
the first postoperative day.
HEMogloBIn
Figure 4 shows a lower postoperative decline in hemo-
globin values in the trasylol groups. the difference is
not significant.
InFECtIon RAtE
We could not find a difference in the infection rate in
all groups. 
CoAgulAtIon
the  postoperative  coagulation  values  are  shown  in
Figure 5. no significant difference was detected be-
tween the trasylolﾮ and the placebo group. 
PlAtElEt ConCEntRAtIon
Figure 6 shows the platelet concentration before and
after surgery. no significant difference was detected
between the trasylolﾮ and the placebo group. 
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Fig.  3.  Box  and  Whisker
Plot  of  the  perioperative
blood  loss.  the  upper  line
of  the  box  shows  the  75%
quartile  of  all  values,  the
lower line the 25% quartile.
the line in the middle of the
box is the median. 
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Fig. 5. Postoperative changes
of Quick values of each group
in relation to baseline.
Fig. 6. Postoperative changes
in  platelet  concentration  of
each group in relation to base-
line.
Fig.  4.  Postoperative  decline
in hemoglobin values.
4) Bölke_Umbruchvorlage  14.01.11  12:08  Seite 24AdvERsE EvEnts
In the trasylolﾮ/drainage and trasylolﾮ/compression
group, one patient each showed an allergic reaction to
trasylolﾮ and  was  excluded  from  the  study.  In  the
placebo/drainage  group,  one  patient  developed  a 
postoperative  hematoma  which  had  to  be  drained 
surgically  on  the  8th postoperative  day  with  conse-
quent removal of the prosthesis due to wound infec-
tion. the further course of this patient was unevent-
ful.  Another  patient  had  the  drainage  removed  due 
to abundant secretion from the wound. the further
postoperative  clinical  course  was  uneventful.  In 
the  placebo/  compression  group,  one  patient  devel-
oped  a  large  postoperative  hematoma  which  was
growing in size and was initially treated conservatively.
since  a  dislocation  of  the  prosthesis  occurred 
during mobilization revision of the hip with prosthesis
changes  was  performed  at  6th postoperative  day. 
the further course was uneventful. In another patient
a bad-fit brace had to be removed after 24 hours. In
the  further  course  no  additional  complications  oc-
curred.
dIsCussIon
the extent of perioperative blood loss is undoubtedly
an important aspect of surgical quality. the objective
of operative drainage is to avoid the loss of blood and
wound  fluid.  yet,  these  can  be  a  potential  breeding
ground for bacteria or inhibit adequate wound healing.
In recent years, the routine use of wound drainage was
questioned due to a lack of data on the benefit of the
drainage  of  blood  or  secretions  on  wound  healing.
Moreover,  several  publications  suggest  that  wound
drainage can result in an increased hemoglobin drop
with a higher rate of blood transfusions, especially in
endoprosthetic surgery of the knee or hip joint. In a
retrospective study of 364 patients with a hip prosthe-
sis  implantation,  Hallstrom  and  steele  compared
wound drainage with wound compression and found a
significant  higher  difference  in  blood  loss  for  the
drainage group [21]. Ritter et al. demonstrated that to-
tal  hip  replacement  with  drainage  increased  transfu-
sion volume on an average of 95 ml of blood per pa-
tient  as  compared  to  total  hip  replacement  without
drainage [49]. However, no increased transfusion re-
quirements  were  documented  after  implantation  of
knee replacement. A retrospective study by Reilly et al.
for knee replacement revealed a significant decline in
hemoglobin and a significantly higher transfusion rate
in patients with wound drainage [47].
In this study, we demonstrated that the blood loss
in the suction drainage group was about 500 ml per
patient higher than in the compression group. It has to
be noted that the blood loss via the drains, underwent
a degree of dilution by serous tissue fluid. determina-
tion of hematocrit in the defect is a more accurate de-
tection for blood loss. With regard to systemic hemo-
globin,  no  statistically  significant  difference  between
the drainage and compression groups was evident and
no hemoglobin decline was found in any group post-
operatively. the higher blood loss rate of the drainage
group  did  not  translate  into  hemoglobin  decreases.
However, this rather reflects the behavior of the hos-
pital transfusion rules than the actual blood loss. In
not  drained  wounds  more  ecchymoses  occur.  Hall-
strom  and  steele  reported  a  hematoma  rate  in  the
undrained wounds of 11.4% versus 2.3% in drained
wounds and Holt et al. describe 69% versus 39% [21].
In  addition,  secondary  hematomas  have  been  de-
scribed after removal of drains. Werner et al. attributes
this to the destruction of vascular structures, which
are  attracted  to  the  vacuum  in  the  lumen  of  the
drainage  [58].  Kirschner,  Wolter  and  tittel  et.  al.
showed that the drains under "high vacuum" condi-
tions (about 80 kPa) are just of short time use, since
the lumen of the drainage tube is quickly occluded by
aspirated tissue [31, 55, 60]. Parker suggests that the
hematoma rate is not affected by drainage [43]. Even
in our study we found a hemato-seroma one week af-
ter the removal of the drainage tube .
An  additional  parameter  for  measuring  the  total
postoperative blood loss was ultrasound examination
of the wound area, which allows a reasonable estimate
of any fluid collection. In our study we did not find
hematoma as frequently in the compression group as
compared to the drainage group.
Bacteria show a high affinity to polymeric materials.
In fact, they produce a biofilm that firmly adheres to
the plastic structure. Herein, drains serve as a kind of
an entry into the wound area, representing a potential
risk  factor  for  an  increased  postoperative  infection
rate, which we could not find in our study [24-26, 31,
32].  this  reflects  the  ambivalence  between  sensible
drainage of wound secretion and potential risk of in-
fection  which  asks  for  appropriate  hygiene  when
changing  wound  dressings  and  limited  duration  of
drainage therapy. Willett et al. found a colonization of
the wound fluid at the free end of the drainage tube in
6% of patients (n = 120) [59]. Also Knapp et al. re-
ported  a  contamination  of  14.4%  of  all  drainage
tubes, while the aspirated wound fluid was infected in
only 7.4% [32]. With regard to the incidence of wound
infections in drained and non-drained wounds no sig-
nificant difference was found in our study. this result
correlates with the literature, stating that the perioper-
ative infection risk and wound healing are not affected
by  dropping  the  existence  of  postoperative  wound
drainage.  With  sufficient  postoperative  tissue  com-
pression and venous thrombosis prophylaxis (thus in-
creasing  venous  return    and  hemostasis)  unimpeded
wound healing can be expected. this mechanical way
of  hemostasis  counteracts  the  formation  of
hematomas, thus making a contribution to an undis-
turbed wound healing. the compression of the wound
increases the local pressure gradient in the tissue and
causes a redistribution of water as an anti-edematous
effect. However, compression may cause serious com-
plications. shall et al. conducted that a too tight com-
pression may aggravate chronic arterial occlusive dis-
ease up to ischemia, resulting in pain and eventually ir-
reparable  tissue  damage      [58].  similarly,  a  localized
compression such as a drastic pressure bandage may
cause venous stasis, which paradoxically increases the
risk of straight bleeding and thromboembolic compli-
cations. A correct bandaging technique should achieve
a uniformly increasing pressure gradient from proxi-
mal to distal on the extremity, resulting in prophylaxis
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In  our  study,  we  used  ProThera-H￼ftorthesen (Poly-
Medics, Peer Belgium), which were individually adapt-
ed preoperatively to patients‘ proximal thigh. 
only once the brace had to be removed because of
pain and a loose fit after 24 hours. In comparison to
winding  compression  bandages,  the  procedure  was
perceived by patients as comfortable and gave stabiliz-
ing.  Even  in  the  absence  of  drainage  therapy,  there
was no increase in the rate of hematoma. Additionally,
there was a reduction of postoperative blood loss.
Furthermore,  we  investigated  the  effect  of  apro-
tinin on perioperative blood loss. Recent research re-
sults from cardiovascular and orthopedic surgery, a de-
scribed reduction in perioperative blood loss due to
aprotinin medication has been described [4-6]. the an-
tifibrinolytic effect of aprotinin raises the question of
favoring  intravascular  thrombosis.  In  formal  testing,
no  significantly  increased  rates  of  thrombosis  have
been shown. one explanation for this is that aprotinin
causes a stabilization of the platelet membranes. this
results  in  inhibition  of  thromboxan  release  and
platelet aggregation which counteracts clot formation.
the  desired  hemostasis  by  aprotinin  is  therefore
not  associated  with  increased  thrombogenesis  and
does not increase the thromboembolic risk. this con-
cept is in line with our study, as we did not find any
evidence of any aprotinin induced increase thrombot-
ic events. However, it is important to note that only
clinically manifest thromboses were recorded, a target-
ed search, with the help of a venography was not per-
formed routinely. 
Murkin et al. investigated in several studies the im-
pact and side effects of aprotinin in surgical proce-
dures [39, 40]. With bilateral implantation of hip joint
prostheses or hip arthrodeses the average blood loss
was reduced by trasylolﾮ from 2098 ml to 1498 ml,
without increased incidence of deep venous thrombo-
sis. Also samama and leche et al. obtained in their
studies a similar result regarding the influence of apro-
tinin  in  orthopedic  surgery  a  similar  result  [51,  52].
similarly Jeserschek et al. could show in a prospective
randomized study a significant reduction of blood loss
after administration of high dose aprotonin when per-
forming hip and knee replacements and excisions of
soft tissue sarcoma [29].
on the other hand, Kasper et al. didn’t find a re-
duction  in  blood  loss  by  aprotinin  medication  in
arthroplasties of  the hip [30, 35]. our own study pro-
vided a similar result, since with aprotinin treatment
the overall blood loss was not affected. the difference
in  total  blood  loss  between  trasylolﾮ and  placebo
groups was clinically insignificant and without statisti-
cal significance. Aprotinin had no discernible effect on
the amount of transfused blood. 
Meanwhile, despite the possibility of a modest re-
duction in the risk of massive bleeding, the strong and
consistent negative mortalitytrendassociatedwithapro  -
tinin, as compared with the lysine analogues, precludes
its use in high-risk cardiac surgery. Following the results
of the “BARt trial” the manufacturer has withdrawn
trasylolﾮ from the market. [1, 2, 8, 13, 14, 16, 17, 27,
33, 36-38, 41, 44-46, 48, 53, 54, 57] Even in our study
two patients developed severe allergic side effects. 
ConClusIon
our study shows that the blood loss in hip surgery is
not reduced by the use of aprotinin. Furthermore it
seems that wound drainage is not necessary when an
external compression of the wound is performed.
Acknowledgement: this  work  is  dedicated  to  thomas  and
Anni speer
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